SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022607
Filing Date
2022-11-07
Accepted
2022-11-07 16:13:43
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmea-20220930.htm   iXBRL 10-Q 3360123
2 EX-31.1 bmea-ex31_1.htm EX-31.1 21374
3 EX-31.2 bmea-ex31_2.htm EX-31.2 21384
4 EX-32.1 bmea-ex32_1.htm EX-32.1 11679
5 EX-32.2 bmea-ex32_2.htm EX-32.2 11525
  Complete submission text file 0000950170-22-022607.txt   9223808

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmea-20220930_def.xml EX-101.DEF 153174
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmea-20220930_pre.xml EX-101.PRE 273989
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmea-20220930_cal.xml EX-101.CAL 38210
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmea-20220930_lab.xml EX-101.LAB 383027
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmea-20220930.xsd EX-101.SCH 39681
54 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20220930_htm.xml XML 1601242
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40335 | Film No.: 221365590
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences